Cann Group Ltd Total Assets

Latest as of December 2025: AU$55.54 Million AUD ≈ $39.30 Million USD

Cann Group Ltd total assets. Based on the latest financial reports, Cann Group Ltd (CAN) holds total assets worth AU$55.54 Million AUD (≈ $39.30 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see CAN company net worth for the company's overall valuation and market capitalisation.

Total Assets of Cann Group Ltd (2015–2025)

Total assets of Cann Group Ltd from 2015 to 2025. This chart illustrates how Cann Group Ltd's total assets have evolved over time, based on quarterly financial data. See latest Cann Group Ltd stock price today for real-time trading data and today's change.

Cann Group Ltd - Asset Composition Analysis

Cann Group Ltd Total Assets Breakdown (June 2025)

Cann Group Ltd total assets breakdown as of June 2025. Cann Group Ltd's total assets of AU$55.54 Million consist of 12.2% current assets and 87.9% non-current assets.

Asset Category Amount (AUD) % of Total Assets
Cash & Equivalents AU$10.00K 0.0%
Accounts Receivable AU$587.00K 0.8%
Inventory AU$4.34 Million 5.5%
Property, Plant & Equipment AU$69.17 Million 87.8%
Intangible Assets AU$9.00K 0.0%
Goodwill AU$0.00 0.0%

Asset Composition Trend (2015–2025)

This chart illustrates how Cann Group Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Cann Group Ltd (CAN) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Cann Group Ltd's current assets represent 12.2% of total assets in 2025, a decrease from 76.4% in 2015.
  • Cash Position: Cash and equivalents constituted 0.0% of total assets in 2025, down from 62.1% in 2015.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
  • Asset Diversification: The largest asset category is property, plant & equipment at 87.8% of total assets.

Cann Group Ltd Competitors by Total Assets

Key competitors of Cann Group Ltd based on total assets are shown below.

Company Country Total Assets
Viatris Inc
NASDAQ:VTRS
USA $35.04 Billion
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
China CN¥11.59 Billion
Walvax BioTech
SHE:300142
China CN¥10.50 Billion
Curaleaf Holdings Inc.
TO:CURA
Canada CA$2.88 Billion
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026
China CN¥10.37 Billion
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
China CN¥3.23 Billion
Renhe Pharmacy Co Ltd
SHE:000650
China CN¥7.93 Billion
Harbin Gloria Pharmaceuticals
SHE:002437
China CN¥3.14 Billion

Cann Group Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.42 0.16 12.86
Quick Ratio 0.12 0.04 9.60
Cash Ratio 0.05 0.00 8.23
Working Capital AU$-12.10 Million AU$-65.92 Million AU$39.87 Million

Cann Group Ltd - Advanced Valuation Insights

This section examines the relationship between Cann Group Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.17
Latest Market Cap to Assets Ratio 0.06
Asset Growth Rate (YoY) -15.1%
Total Assets AU$78.79 Million
Market Capitalization $4.98 Million USD

Valuation Analysis

Below Book Valuation: The market values Cann Group Ltd's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Cann Group Ltd's assets decreased by 15.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Cann Group Ltd (2015–2025)

The table below shows the annual total assets of Cann Group Ltd from 2015 to 2025.

Year Total Assets Change
2025-06-30 AU$78.79 Million
≈ $55.75 Million
-15.07%
2024-06-30 AU$92.77 Million
≈ $65.64 Million
-28.34%
2023-06-30 AU$129.47 Million
≈ $91.61 Million
-7.30%
2022-06-30 AU$139.66 Million
≈ $98.82 Million
+37.20%
2021-06-30 AU$101.79 Million
≈ $72.02 Million
+33.23%
2020-06-30 AU$76.40 Million
≈ $54.06 Million
-6.96%
2019-06-30 AU$82.11 Million
≈ $58.10 Million
-5.40%
2018-06-30 AU$86.80 Million
≈ $61.42 Million
+475.83%
2017-06-30 AU$15.07 Million
≈ $10.67 Million
-5.16%
2016-12-31 AU$15.89 Million
≈ $11.25 Million
+749.38%
2016-06-30 AU$1.87 Million
≈ $1.32 Million
+157.70%
2015-06-30 AU$726.15K
≈ $513.80K
--

About Cann Group Ltd

AU:CAN Australia Drug Manufacturers - Specialty & Generic
Market Cap
$5.87 Million
AU$8.30 Million AUD
Market Cap Rank
#28531 Global
#1499 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$3.98
About

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.